FDA’s booster plan should be ready in September, sources say

The FDA expects to establish the national strategy on COVID-19 booster shots by early September to determine when and which vaccinated Americans should get third doses, sources familiar with the discussion told The Wall Street Journal Aug. 5.

Advertisement

The plan will prioritize people who are immunocompromised, older or received their shots shortly after COVID-19 vaccines were approved last winter, the sources said. 

Pfizer said July 8 that it plans to file for FDA authorization for a third dose of its vaccine. Moderna said Aug. 5 booster shots for its vaccine will most likely become necessary before winter to combat the rapid spread of the delta variant.

The news about the country’s boosters timeline comes two days after the World Health Organization called for a moratorium on COVID-19 boosters until vaccination rates pick up globally. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.